The cellular immunity in cancer patients

DNCB test and its prognostic implications

Authors

  • Guillermo Dighiero
  • Mercedes Lassus
  • Fabio Lima
  • Gladys Martínez de Lima
  • Julio C Priario

Keywords:

malign tumors, inmunity

Abstract

20 normal subjects and 72 neoplasic were testea for their ability to develop delayed cutaneous sensitivity to dinitrochlorobenzene (DNCB). There was a
statistical!y significant difference between the reaction of normal subjects· (95 % positives) and neoplasic population ( 50 % ) . Patients who were able to react to DNCB had a
significantly better short-term (six and twelve months) prognosis than those who were anergic, and this correlation was also significant in those patients who exhibited
advanced neoplasic disease. This study suggests that there might be a significant correlation between the reaction to DNCB and the course of malignant disease.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Published

1974-02-23

How to Cite

1.
Dighiero G, Lassus M, Lima F, Martínez de Lima G, Priario JC. The cellular immunity in cancer patients: DNCB test and its prognostic implications. Cir. Urug. [Internet]. 1974 Feb. 23 [cited 2024 Jul. 3];44(3):172-4. Available from: https://revista.scu.org.uy/index.php/cir_urug/article/view/2592

Issue

Section

Original Article

Most read articles by the same author(s)

<< < 1 2 3 4 > >>